Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Healthy Volunteer AND Healthy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    199 result(s) found for: Healthy Volunteer AND Healthy. Displaying page 1 of 10.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2004-005127-17 Sponsor Protocol Number: KIN-DLC-04 Start Date*: 2005-06-08
    Sponsor Name:pharmed holding GmbH
    Full Title: Potentiation of the antihyperalgesic effects of topically applied diclofenac by concomitant use of topical lidocaine
    Medical condition: Healthy volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005443-26 Sponsor Protocol Number: 9813 Start Date*: 2006-03-03
    Sponsor Name:Greater Glasgow Health Board
    Full Title: Effect site controlled, reaction time safeguarded, patient maintained sedation with propofol in Healthy Volunteers
    Medical condition: IMP will be used to provide conscious sedation for healthy volunteers. No medical condition
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2005-000974-29 Sponsor Protocol Number: TH0501 Start Date*: 2005-04-01
    Sponsor Name:Boots Healthcare International Limited
    Full Title: An open label, oral bioavailability study to determine the levels of Amylmetacresol BP (AMC) and 2,4-dichlorobenzyl alcohol (DCBA) in the saliva of healthy volunteers after a single oral dose of S...
    Medical condition: AMC and DCBA are indicated for the symptomatic relief of mouth and throat infections.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004764-31 Sponsor Protocol Number: 02-2006 Start Date*: 2007-01-11
    Sponsor Name:Max Planck Institute of Psychiatry
    Full Title: Effects of corticotropin-releasing hormone on sleep electroencephalogram and sleep associated hormone secretion in young healthy women
    Medical condition: Healthy volunteers. The aim is to test the effects of CRH on sleep electroencephalogram and sleep associated secretion of growth hormone and cortisol
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015902-20 Sponsor Protocol Number: GHB-CS07 Start Date*: 2009-11-04
    Sponsor Name:AVIR Green Hills Biotechnology Research Development Trade AG
    Full Title: Randomized, double-blind, placebo-controlled, Phase IIa dose finding study of single dose GHB11L1 in healthy adults
    Medical condition: GHB-CS07 is a healthy volunteer trial. The intended indication for the investigational medicinal product (GHB11L1) is prevention of influenza A (H1N1).
    Disease: Version SOC Term Classification Code Term Level
    12.0 10022002 Influenza A virus infection LLT
    Population Age: Adults Gender: Male
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004082-42 Sponsor Protocol Number: OXY-2 Start Date*: 2005-12-05
    Sponsor Name:Søren Sindrup, Dept. of Neurology, University Hospital of Odense
    Full Title: The Pharmacogenetics of Oxycodone analgesia in human experimental pain models
    Medical condition: Healthy volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2005-001639-30 Sponsor Protocol Number: TramaPara8405 Start Date*: 2006-10-02
    Sponsor Name:Department of Anaesthesia&Intensive Care B, Vienna Medical University
    Full Title: Investigation of the antihyperalgesic effect of a combination of tramadol and paracetamol on primary and secondary hyperalgesia in an UV-B induced inflammatory skin pain model in healthy volunteers.
    Medical condition: This is a volunteer study in healthy volunteers.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2015-003005-41 Sponsor Protocol Number: CS0866-A-U101 Start Date*: 2015-07-24
    Sponsor Name:Sankyo Pharma Development
    Full Title: A Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of a Compounded 4 mg/mL Olmesartan Medoxomil Suspension (Total Dose 40 mg) and 40 mg Olmesartan Medoxomil Tablets (Beni...
    Medical condition: Not applicable - Healthy Volunteer study
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2006-001491-21 Sponsor Protocol Number: 1-2006 Start Date*: Information not available in EudraCT
    Sponsor Name:Max Planck Institute of Psychiatry
    Full Title: Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning
    Medical condition: Effects on sleep electroencephalogram and motoric learning in healthy volunteers related to the permeability of the blood-brain-barrier related to genotypes of the ABCB 1 gene
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-001915-78 Sponsor Protocol Number: RBM/2004.20 Start Date*: 2005-12-06
    Sponsor Name:Institut Pasteur
    Full Title: A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of two doses 10 ^5 and 10^7 CFU of SC599 oral vaccine, a Live Attenuated Shigella dysenteriae 1 vaccine strain in ...
    Medical condition: Healthy Volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-005143-28 Sponsor Protocol Number: MED.RES.HOS.2006.03.LP Start Date*: 2006-12-06
    Sponsor Name:Medicinsk Forskning
    Full Title: Effects of HMG-CoA-reductase inhibition (atorvastatin) on renal sodium excretion, renal hemodynamics, tubular function and vasoactive hormones in healthy subjects under diet with normal and high so...
    Medical condition: Healthy volunteer trial
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-002602-39 Sponsor Protocol Number: 1562016 Start Date*: 2016-10-25
    Sponsor Name:Radboud University Medical Center
    Full Title: FGF23 response in hypophosphatemia
    Medical condition: healthy volunteers the information of this pilot study will be used in the care of patients with hypophosphatemia due to renal phosphate wasting
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-005695-14 Sponsor Protocol Number: 3165A1-1108-EU Start Date*: 2008-01-18
    Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Research and Development
    Full Title: A Double-Blind, Placebo-Controlled, Randomized, Single-Dose, 2-Period Crossover Study of the Pharmacodynamics of Orally Administered PSI-697 in Healthy Subjects Who Smoke
    Medical condition: PSI-697 is an orally active inhibitor of the cellular adhesion molecule P-selectin that offers a unique, first in class mechanism for preventing the vascular atherothrombotic state that is driven b...
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-000408-16 Sponsor Protocol Number: HS-PM-013 Start Date*: 2005-04-05
    Sponsor Name:Karolinska University Hospital, Huddinge
    Full Title: Caffeine-mediated modulation of human experimental pain models
    Medical condition: Healthy human volunteer subjects
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-004426-93 Sponsor Protocol Number: lido_caps_sb_200509 Start Date*: 2005-10-28
    Sponsor Name:Department of Anaesthesia and General Intensive Care Medicine
    Full Title: Investigation of antihyperalgesic effect...
    Medical condition: volunteer study with healthy volunteers using the intradermal capsaicin injection and UV-B sunburn as models of hyperalgesia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-005649-12 Sponsor Protocol Number: SUCPAT1_CTR0026 Start Date*: 2006-12-20
    Sponsor Name:Regent Medical
    Full Title: A 96 hour (4-application) patch test and TEWL assessment in healthy volunteers to investigate the comparative skin irritation potential of six antiseptics and two controls following cutaneous patch...
    Medical condition: This trial will be carried out on healthy volunteers. Patches containing 0.2mls of each test product will be used. Each volunteer will have a single patch per product and the patches will be remov...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-009177-10 Sponsor Protocol Number: BAY86-5016/14348 Start Date*: 2009-04-30
    Sponsor Name:Bayer HealthCare AG
    Full Title: Multicenter, open-label, randomized study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestodene in health...
    Medical condition: The trial will be performed in healthy female volunteers. The intended indication is femal contraception.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-001198-13 Sponsor Protocol Number: 310805 Start Date*: 2008-08-19
    Sponsor Name:Bayer HealthCare AG/Bayer Schering Pharma AG
    Full Title: Multicenter, open-label, randomized, uncontrolled study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gesto...
    Medical condition: The trial will be performed in healthy female volunteers. The indended indication is female contraception.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-010599-45 Sponsor Protocol Number: BAY86-5016/14287 Start Date*: 2009-06-04
    Sponsor Name:Bayer HealthCare AG
    Full Title: Single-center, open-label, uncontrolled study to investigate the effects of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestodene (material no. 80876395) on t...
    Medical condition: Healthy volunteer trial, intended indication: Prevention of pregnancy
    Disease: Version SOC Term Classification Code Term Level
    9.1 10060346 Transdermal contraception LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-002092-28 Sponsor Protocol Number: acotiamide1 Start Date*: 2017-04-19
    Sponsor Name:KULeuven - TARGID
    Full Title: The effect of acotiamide on gastric motility and satiation in healthy volunteers
    Medical condition: Funtional gastroenterological disorder: Functional Dyspepsia more specific the postprandial distress syndrome.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 02 08:18:06 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA